Summary
The Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) is seeking a postdoctoral researcher to focus on preclinical validation of a novel immunotherapy, MACTIDE-V, for metastatic triple-negative breast cancer. The successful candidate will possess entrepreneurial aspirations to lead a spin-off aimed at developing this therapeutic asset.
Postdoctoral Position in Breast Cancer Research, Barcelona, Spain
Designation
Postdoctoral Researcher
Details
| Field | Details |
|---|---|
| Research Area | Immunotherapy for metastatic triple-negative breast cancer |
| Location | Barcelona, Spain |
| Contract Duration | 1 year |
| Salary | According to Spanish work personnel group M3 |
| Target Start Date | Immediately |
Eligibility / Qualification
- Education: PhD in biology, biochemistry, immunology, or a related field.
- Experience: Proven experience in working with mouse models and conducting therapeutic efficacy studies.
- Competencies:
- Knowledge in ADME (Absorption, Distribution, Metabolism, Excretion) studies.
- Proficient in multichannel flow cytometry, histology, and working with patient-derived organoids.
- Background in business and entrepreneurship is a plus.
Job Description
The postdoctoral researcher will:
- Conduct preclinical studies to validate the effectiveness of the MACTIDE-V peptide-drug conjugate.
- Engage in entrepreneurial activities to establish and lead a spin-off company focused on developing the immunotherapy.
- Collaborate with interdisciplinary teams and contribute to academic publications.
How to Apply
Interested candidates should submit their CV and a motivation letter via email to Pablo Scodeller at pablo.scodeller@iqac.csic.es with “Postdoc” in the email subject line.
Last Date to Apply
Applications will be accepted until October 4, 2026.
This post outlines the essential details and requirements for the position, inviting suitable candidates to apply.
